Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with high mortality, poor prognosis, and palliative treatments, due to the rapid upregulation of alternative compensatory pathways and desmoplastic reaction. miRNAs, small non-coding RNAs, have been recently identified as key player...
Main Authors: | Nagabhishek Sirpu Natesh, Brianna M. White, Maia M. C. Bennett, Metin Uz, Rakhee Rathnam Kalari Kandy, Surinder K. Batra, Surya K. Mallapragada, Satyanarayana Rachagani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/12/1987 |
Similar Items
-
Overexpression of microRNA-345 Affects the Invasive Capacity of Pancreatic Ductal Adenocarcinoma Cell Lines by Suppressing MUC1 and TJP2 Expression
by: Shigenobu Tatsumi, et al.
Published: (2022-05-01) -
Gut microbiota: a non-target victim of pesticide-induced toxicity
by: Tusha Sharma, et al.
Published: (2023-12-01) -
MicroRNA‐345‐5p regulates depression by targeting suppressor of cytokine signaling 1
by: Yulan Liu, et al.
Published: (2020-09-01) -
Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma
by: Beáta Scholtz, et al.
Published: (2022-02-01) -
miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
by: Noemi Arrighetti, et al.
Published: (2021-03-01)